Table 2.
Distribution of urinary paraben concentrations (µg/L) (n = 2,721 samples) among 653 study participants.a
| Analyte | Individual samples | Within-person GMb | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Percent detectc | GM | Minimum | 25th percentile | 50th percentile | 75th percentile | Maximum | n | Minimum | 25th percentile | 50th percentile | 75th percentile | Maximum | |||||
| MP | ||||||||||||||||||
| All subjects | 2,721 | 99.7 | 100 | < LOD | 31.3 | 112 | 354 | 23,200 | 653 | < LOD | 30.4 | 82.2 | 236 | 7,110 | ||||
| Sex | ||||||||||||||||||
| Female | 2,128 | 99.9 | 137 | < LOD | 48.8 | 155 | 422 | 15,100 | 408 | 2.56 | 55.1 | 149 | 299 | 7,110 | ||||
| Male | 593 | 99.3 | 33.0 | < LOD | 10.0 | 29.0 | 96.7 | 23,200 | 245 | < LOD | 12.8 | 31.2 | 81.0 | 2,880 | ||||
| Race | ||||||||||||||||||
| Caucasian | 2,320 | 99.7 | 97.1 | < LOD | 29.9 | 104 | 332 | 23,200 | 552 | < LOD | 28.0 | 75.3 | 219 | 7,110 | ||||
| African American | 87 | 100 | 343 | 8.10 | 158 | 362 | 868 | 4,730 | 27 | 57.6 | 158 | 340 | 907 | 3,880 | ||||
| Asian | 164 | 100 | 92.2 | 1.20 | 28.5 | 104 | 346 | 1,860 | 43 | 4.57 | 25.1 | 91.0 | 241 | 1,073 | ||||
| Other | 150 | 100 | 92.3 | 1.80 | 31.1 | 96.4 | 319 | 3,330 | 31 | 6.00 | 37.9 | 97.0 | 204 | 1,308 | ||||
| PP | ||||||||||||||||||
| All subjects | 2,721 | 96.5 | 17.9 | < LOD | 4.00 | 24.2 | 90.2 | 2,870 | 653 | < LOD | 3.49 | 15.4 | 53.1 | 2,510 | ||||
| Sex | ||||||||||||||||||
| Female | 2,128 | 98.3 | 27.5 | < LOD | 7.90 | 34.3 | 118 | 2,870 | 408 | < LOD | 9.75 | 28.1 | 78.9 | 2,510 | ||||
| Male | 593 | 90.2 | 3.82 | < LOD | 0.80 | 3.10 | 16.8 | 1,170 | 245 | < LOD | 0.84 | 3.30 | 15.2 | 667 | ||||
| Race | ||||||||||||||||||
| Caucasian | 2,320 | 96.8 | 17.7 | < LOD | 4.00 | 23.6 | 87.0 | 2,550 | 552 | < LOD | 3.24 | 14.6 | 47.8 | 2,510 | ||||
| African American | 87 | 100 | 63.0 | 1.30 | 22.4 | 88.4 | 198 | 1,170 | 27 | 2.00 | 15.9 | 95.6 | 177 | 318 | ||||
| Asian | 164 | 95.7 | 16.3 | < LOD | 3.85 | 22.2 | 93.2 | 909 | 43 | 0.24 | 3.00 | 18.9 | 40.6 | 370 | ||||
| Other | 150 | 90.7 | 10.8 | < LOD | 1.80 | 13.2 | 84.3 | 2,870 | 31 | < LOD | 3.60 | 10.9 | 52.8 | 467 | ||||
| BP | ||||||||||||||||||
| All subjects | 2,721 | 65.4 | 1.08 | < LOD | < LOD | 0.70 | 5.40 | 998 | 653 | < LOD | < LOD | 0.59 | 2.80 | 208 | ||||
| Sex | ||||||||||||||||||
| Female | 2,128 | 73.6 | 1.48 | < LOD | < LOD | 1.20 | 7.65 | 595 | 408 | < LOD | 0.35 | 1.30 | 4.47 | 128 | ||||
| Male | 593 | 35.9 | 0.35 | < LOD | < LOD | < LOD | 0.50 | 998 | 245 | < LOD | < LOD | < LOD | 0.70 | 208 | ||||
| Race | ||||||||||||||||||
| Caucasian | 2,320 | 65.8 | 1.11 | < LOD | < LOD | 0.70 | 5.80 | 998 | 552 | < LOD | < LOD | 0.59 | 2.80 | 208 | ||||
| African American | 87 | 77.0 | 1.34 | < LOD | 0.20 | 1.10 | 6.10 | 93.8 | 27 | < LOD | < LOD | 0.96 | 4.09 | 27.3 | ||||
| Asian | 164 | 57.9 | 0.88 | < LOD | < LOD | 0.35 | 3.75 | 194 | 43 | < LOD | < LOD | 0.44 | 2.19 | 95.1 | ||||
| Other | 150 | 61.3 | 0.77 | < LOD | < LOD | 0.50 | 2.80 | 112 | 31 | < LOD | < LOD | 0.44 | 2.19 | 95.1 | ||||
| aValues were not corrected for SG to facilitate comparison with other studies. bThe within-person GM was used as a summary exposure measure for each subject. cLOD: MP = 1 µg/L; PP = 0.2 µg/L; BP = 0.2 µg/L. | ||||||||||||||||||